← SynDRA
LEMBOREXANT
SynDRA canonical compound SYN0038287 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | HCRTR1 | HCRTR2 |
|---|
| Mechanism of action | orexin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- HCRTR1 ANTAGONIST
- Orexin receptor 1 antagonist
- HCRTR2 ANTAGONIST
- Orexin receptor 2 antagonist
- orexin receptor antagonist
Drug classes
- Central Nervous System Agents
- Central Nervous System Depressants
- Hypnotics and Sedatives
- Neurotransmitter Agents
- Orexin Receptor Antagonists
- Sleep Aids, Pharmaceutical
- Cytochrome P450 2B6 Inducers
- Orexin Receptor Antagonist
ATC classes
- N05C · HYPNOTICS AND SEDATIVES
Cross-references
Synonyms
- dayvigo
- E2006
- E-2006
- Dayvigo
- 0K5743G68X
- E 2006
- lemborexantum
- RefChem:56887
- DTXCID001513507
- Lemborexant [USAN:INN]
- UNII-0K5743G68X
- Dayvigo (TN)
- Lemborexant [INN]
- Lemborexant(E2006)
- LEMBOREXANT [MI]
- Lemborexant(E2006)?
- Lemborexant; E-2006
- LEMBOREXANT [JAN]
- LEMBOREXANT [USAN]
- orb14385
- LEMBOREXANT [WHO-DD]
- Lemborexant (JAN/USAN/INN)
- GTPL9302
- SCHEMBL2116558
- SCHEMBL29521503
- LEMBOREXANT [ORANGE BOOK]
- DEA NO. 2245
- MUGXRYIUWFITCP-PGRDOPGGSA-N
- GLXC-90502
- EX-A2337
- BDBM50093793
- compound 34 [PMID: 25953512]
- NCGC00488783-01
- NCGC00488783-02
- AC-30918
- FL103847
- HY-16725
- MS-27073
Reported adverse events
- Cataplexy
- Depression
- Hallucination
- Headache
- Hypnagogic hallucination
- Nightmare
- Sleep paralysis
- Somnolence
Look up LEMBOREXANT in the interactive SynDRA portal →